Home > Balance Sheet > BIOCON

BIOCON
Contingent Liabilities

    Back to Balance Sheet
BIOCON is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Top Undervalued Mid Cap Stocks
COMMUNITY POLL
for BIOCON
Please provide your vote to see the results

BIOCON Last 5 Year Contingent Liabilities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Contingent Liabilities ₹1,176 Cr₹1,136 Cr₹948 Cr₹844 Cr₹700 Cr

What is the latest Contingent Liabilities ratio of BIOCON ?

The latest Contingent Liabilities ratio of BIOCON is ₹1,176 Cr based on Mar2025 Consolidated results.
Year Contingent Liabilities
Mar2025₹1,176 Cr
Mar2024₹1,136 Cr
Mar2023₹948 Cr
Mar2022₹844 Cr
Mar2021₹700 Cr

How is Contingent Liabilities of BIOCON Trending?

Years Contingent Liabilities % Change
Mar2025 ₹1,176 Cr
3.57
Mar2024 ₹1,136 Cr
19.81
Mar2023 ₹948 Cr
12.25
Mar2022 ₹844 Cr
20.63
Mar2021 ₹700 Cr -

Compare Contingent Liabilities of peers of BIOCON

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BIOCON ₹48,693.5 Cr 4.7% -8.9% 6.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹391,667.0 Cr 3.5% -3.4% -5.8% Stock Analytics
DIVIS LABORATORIES ₹163,697.0 Cr 3.7% -10.2% 25.6% Stock Analytics
CIPLA ₹126,365.0 Cr 5.3% 6.1% -1.3% Stock Analytics
TORRENT PHARMACEUTICALS ₹123,639.0 Cr 1.4% 4.6% 7.6% Stock Analytics
DR REDDYS LABORATORIES ₹105,479.0 Cr 3.9% 0% -9.9% Stock Analytics


BIOCON Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
BIOCON

4.7%

-8.9%

6.9%

SENSEX

1.8%

-1.7%

2.9%


You may also like the below Video Courses